Glovadalen, a novel D1 receptor positive allosteric modulator, is linked to improve OFF time in patients with Parkinson’s ...
Migraine Again on MSN
The Complete Guide to Migraine Relief: What’s New and What’s Still Tried-and-True
There are many effective acute and preventive migraine treatment options available today, including whole new medication ...
Gilead Sciences, Inc. (Nasdaq: GILD) will present new findings from its antiviral research and development programs at IDWeek, taking place October 19-22 in Atlanta, GA. Data from 34 presentations ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback